Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial-Reference-Cited by-同舟云学术

Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial

Published:2013-04 Issue:4 Volume:14 Page:317-326
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Mukherjee Somnath,Hurt Christopher N,Bridgewater John,Falk Stephen,Cummins Sebastian,Wasan Harpreet,Crosby Tom,Jephcott Catherine,Roy Rajarshi,Radhakrishna Ganesh,McDonald Alec,Ray Ruby,Joseph George,Staffurth John,Abrams Ross A,Griffiths Gareth,Maughan Tim

Funder

Cancer Research UK

Publisher

Elsevier BV

Subject

Oncology

Reference28 articles.

1. Pancreatic cancer;Hidalgo;N Engl J Med,2010

2. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;J Clin Oncol,1997

3. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone;J Natl Cancer Inst,1988

4. Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial;Louvet;J Clin Oncol,2005

5. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. The gastrointestinal tumor study group;Moertel;Cancer,1981

Cited by 293 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Somay’s GLUCAR Index Efficiently Predicts Survival Outcomes in Locally Advanced Pancreas Cancer Patients Receiving Definitive Chemoradiotherapy: A Propensity-Score-Matched Cohort Analysis;Journal of Personalized Medicine;2024-07-13

2. Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinoma;Clinical and Translational Radiation Oncology;2024-07

3. Radiochemotherapy in Pancreatic Cancer;Current Oncology;2024-06-06

4. Neoadjuvant management of locally advanced pancreatic ductal adenocarcinoma − Heading towards a promising change in treatment paradigm;Cancer Treatment Reviews;2024-06

5. Palliative and supportive care underutilization for patients with locally advanced pancreatic cancer: review of the NCDB;ESMO Gastrointestinal Oncology;2024-06